GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Future Policy Benefits

Respiratorius AB (XSAT:RESP) Future Policy Benefits


View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Respiratorius AB Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.